www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
China / Society

Stem-cell trials give new hope to heart patients

By Shan Juan (China Daily) Updated: 2014-08-26 06:53

China's patients with chronic heart failure - a serious and common condition in which the heart cannot pump enough blood - will soon have access to the stem-cell-based therapy C-Cure.

Eight to 10 trial sites are expected to be set up at renowned public medical institutions in Beijing, Shanghai and Guangzhou, in addition to others around the world, to test the safety and effectiveness of the therapy.

"Participating in the trial will enhance the stem-cell research capacity of China, which remains uncompetitive worldwide," said Zhou Yujie, vice-president of Beijing Anzhen hospital.

It is the first stem-cell therapy for cardiology to enter Phase 3 of a clinical trial in China, he noted.

Chronic heart failure affects about 117 million people worldwide, including nearly 30 million in China, according to the World Health Organization and China's National Health and Family Planning Commission.

Current treatments mainly work to slow down progression of the disease, but with the exception of heart transplants they cannot cure the disease, said professor Gu Hong of Anzhen hospital.

"C-Cure is a revolutionary stem-cell treatment for heart failure. If it passes the Phase 3 clinical trial, it will enter the market to save the patients," she said.

The therapy reprograms the patient's own stem cells into new heart cells to rebuild the heart, according to Atta Behfar, director of cardiovascular regeneration at Mayo Clinic in the US.

He has played an active part in developing the technology that directs the patient's cells to become heart cells. Mayo Clinic was also involved in previous clinical trials of C-Cure in the United States.

"Stem-cell therapy aims to teach the human body to heal itself and we're moving gradually from promise to reality," he said.

Xu Guotong, head of the medicine department of Tongji Medical University in Shanghai, agreed but pointed out that China still lags far behind the US.

"The problem lies in a lack of government regulations and policies," he acknowledged.

Between a drug and a therapy, stem-cell treatment needs to be clearly defined by the health and drug authorities in China, he said.

shanjuan@chinadaily.com.cn

Highlights
Hot Topics
...
主站蜘蛛池模板: 鲁丝一区二区三区不属 | 天堂视频在线免费观看 | 亚洲自偷自拍另类12p | 日本视频播放免费线上观看 | 久久丁香 | 一级特级aaaa毛片免费观看 | 亚洲国产二区三区久久 | 大量愉拍情侣在线视频 | 日本一级aaaa特黄毛片 | 欧美午夜不卡在线观看最新 | 99精品国产兔费观看久久99 | 欧美一级毛片香蕉网 | 99精品在线免费 | 午夜毛片视频高清不卡免费 | 很黄的网站在线观看 | 国产精品久久不卡日韩美女 | 亚洲热视频 | 国产一国产一有一级毛片 | 精品久久久久国产 | 思思99re| 男女免费观看在线爽爽爽视频 | 毛片基地免费视频a | 一区二区三区不卡在线 | 99久久国产综合精品2020 | 日韩 国产 欧美 精品 在线 | 毛片大全免费 | 99在线精品视频免费观里 | 久久久毛片 | 欧美日韩另类综合 | 久草在在线视频免费 | 日韩三级视频在线观看 | 欧美一级毛片不卡免费观看 | 国内视频一区 | 日韩中文在线 | 97公开免费视频 | 亚洲免费在线观看视频 | 大片国产片日本观看免费视频 | 在线播放一区二区精品产 | 草久在线观看 | avav在线看 | 免费a级片网站 |